0001209191-15-008075.txt : 20150130 0001209191-15-008075.hdr.sgml : 20150130 20150130212801 ACCESSION NUMBER: 0001209191-15-008075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150128 FILED AS OF DATE: 20150130 DATE AS OF CHANGE: 20150130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 2ND AVE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 2ND AVE CITY: BURLINGTON STATE: MA ZIP: 01803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gebauer Peter R CENTRAL INDEX KEY: 0001365741 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 15564758 MAIL ADDRESS: STREET 1: AM WALDFELD 17 CITY: BAD SODEN STATE: 2M ZIP: 65812 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-01-28 0 0001158895 LEMAITRE VASCULAR INC LMAT 0001365741 Gebauer Peter R C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 0 1 0 0 President, International OP Common Stock 2015-01-28 4 M 0 4094 0.102 A 45960 D Common Stock 2015-01-28 4 S 0 4094 7.9115 D 41866 D Common Stock 2015-01-29 4 M 0 12825 0.102 A 54691 D Common Stock 2015-01-29 4 S 0 12825 7.9056 D 41866 D Stock Option (Right to Buy) 0.102 2015-01-28 4 M 0 4094 0.00 D 1997-06-02 2007-06-02 Common Stock 4094 186295 D Stock Option (Right to Buy) 0.102 2015-01-29 4 M 0 12825 0.00 D 1997-06-02 2007-06-02 Common Stock 12825 173470 D Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. This transaction was effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $7.90 to $7.94. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $7.90 to $7.95. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. This option is fully vested and exercisable. This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency. /s/ Laurie Churchill, Attorney-in-fact 2015-01-30